advertisement
11.16 Vehicles, delivery systems, pharmacokinetics, formulation (105)
Showing records 1 to 25
Search within classification 11.16 Vehicles, delivery systems, pharmacokinetics, formulation79378 Brinzolamide-loaded nanoemulsions: ex vivo transcorneal permeation, cell viability and ocular irritation tests
Mahboobian MM
Pharmaceutical Development and Technology 2019; 24: 600-606
79583 Conjunctival Goblet Cells, the Overlooked Cells in Glaucoma Treatment
Tiedemann D
Journal of Glaucoma 2019; 28: 325-333
79383 Thermosensitive chitosan-gelatin-based hydrogel containing curcumin-loaded nanoparticles and latanoprost as a dual-drug delivery system for glaucoma treatment
Cheng YH
Experimental Eye Research 2019; 179: 179-187
79766 Efficacy of the travoprost/timolol fixed combination versus the concomitant use of travoprost 0.004% and timolol 0.1% gel formulation
Kozobolis V
Clinical Ophthalmology 2018; 12: 2393-2398
79521 Local Delivery and Sustained-Release of Nitric Oxide Donor Loaded in Mesoporous Silica Particles for Efficient Treatment of Primary Open-Angle Glaucoma
Hu C
Advanced healthcare materials 2018; 7: e1801047
80061 Effect of vitamin-E integration on delivery of prostaglandin analogs from therapeutic lenses
Sekar P
Journal of Colloid and Interface Science 2019; 539: 457-467
79769 Thermo-sensitive nanogel-laden bicontinuous microemulsion drug-eluting contact lenses
Lee SH
Journal of Biomedical Materials Research - Part B Applied Biomaterials 2019; 107: 1159-1169
80027 Effect of gold nanoparticles on timolol uptake and its release kinetics from contact lenses: In vitro and in vivo evaluation
Maulvi FA
Acta biomaterialia 2019; 86: 350-362
80090 Rho kinase inhibitors for treatment of glaucoma
Mandell KJ
Expert Review of Ophthalmology 2011; 6: 611-622
79933 Simultaneous co-delivery of neuroprotective drugs from multi-loaded PLGA microspheres for the treatment of glaucoma
Arranz-Romera A
Journal of Controlled Release 2019; 297: 26-38
79825 Engineering and Development of Chitosan-Based Nanocoatings for Ocular Contact Lenses
Mehta P
Journal of Pharmaceutical Sciences 2019; 108: 1540-1551
79363 Efficacy and safety of preservative-free timolol 0.1% gel in open-angle glaucoma and ocular hypertension in treatment-naïve patients and patients intolerant to other hypotensive medications
Lazreg S
Journal Français d'Ophtalmologie 2018; 41: 945-954
79689 Latanoprost with high precision, piezo-print microdose delivery for IOP lowering: clinical results of the PG21 study of 0.4 µg daily microdose
Pasquale LR
Clinical Ophthalmology 2018; 12: 2451-2457
79765 Better tolerance of preservative-free latanoprost compared to preserved glaucoma eye drops: the 12-month real-life FREE study
Economou MA
Clinical Ophthalmology 2018; 12: 2399-2407
79726 Gelatinized core liposomes: A new Trojan horse for the development of a novel timolol maleate glaucoma medication
Hathout RM
International Journal of Pharmaceutics 2019; 556: 192-199
80054 Co-Delivery of Timolol and Brimonidine with a Polymer Thin-Film Intraocular Device
Samy KE; Cao Y
Journal of Ocular Pharmacology and Therapeutics 2019; 35: 124-131
79363 Efficacy and safety of preservative-free timolol 0.1% gel in open-angle glaucoma and ocular hypertension in treatment-naïve patients and patients intolerant to other hypotensive medications
Merad Z
Journal Français d'Ophtalmologie 2018; 41: 945-954
79825 Engineering and Development of Chitosan-Based Nanocoatings for Ocular Contact Lenses
Al-Kinani AA
Journal of Pharmaceutical Sciences 2019; 108: 1540-1551
79726 Gelatinized core liposomes: A new Trojan horse for the development of a novel timolol maleate glaucoma medication
Gad HA
International Journal of Pharmaceutics 2019; 556: 192-199
79583 Conjunctival Goblet Cells, the Overlooked Cells in Glaucoma Treatment
Mouhammad ZA
Journal of Glaucoma 2019; 28: 325-333
79383 Thermosensitive chitosan-gelatin-based hydrogel containing curcumin-loaded nanoparticles and latanoprost as a dual-drug delivery system for glaucoma treatment
Ko YC
Experimental Eye Research 2019; 179: 179-187
79689 Latanoprost with high precision, piezo-print microdose delivery for IOP lowering: clinical results of the PG21 study of 0.4 µg daily microdose
Lin S
Clinical Ophthalmology 2018; 12: 2451-2457
79765 Better tolerance of preservative-free latanoprost compared to preserved glaucoma eye drops: the 12-month real-life FREE study
Laukeland HK
Clinical Ophthalmology 2018; 12: 2399-2407
79766 Efficacy of the travoprost/timolol fixed combination versus the concomitant use of travoprost 0.004% and timolol 0.1% gel formulation
Konstantinidis A
Clinical Ophthalmology 2018; 12: 2393-2398
80061 Effect of vitamin-E integration on delivery of prostaglandin analogs from therapeutic lenses
Chauhan A
Journal of Colloid and Interface Science 2019; 539: 457-467
